Medistep Health Stock Price Today (NSE: MEDISTEP)
Fundamental Score
Medistep Health Share Price Live NSE/BSE & Institutional Fundamental Analysis
Medistep Health share price today is ₹18.75, up +0.00% on NSE/BSE as of 18 March 2026. Medistep Health (MEDISTEP) is a Small-cap company in the Personal Care sector with a market capitalisation of ₹35.52 (Cr). The 52-week high for MEDISTEP share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 6.54x, MEDISTEP is currently trading below its industry average P/E of 50.39x. The company has a Return on Equity (ROE) of 29.02% and a debt-to-equity ratio of 0.02.
Medistep Health Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Medistep Health Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Medistep Health Share Price: A Financial Stability Analysis
The personal care industry, often perceived as recession-resistant due to the consistent demand for essential hygiene products, is currently witnessing increased pricing pressure from both established brands and emerging direct-to-consumer (D2C) models. This analysis examines the financial stability of Medistep Health based on its publicly available data, focusing on the Medistep Health share price of ₹22.799999237060547, its Price-to-Earnings (PE) ratio, and Return on Capital Employed (ROCE). This assessment is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, focusing on observable data points.
Medistep Health's PE ratio of 6.54 is notably lower than many of its sector peers. While a lower PE might suggest undervaluation, it's crucial to consider the company's growth prospects and perceived risk relative to the market. Comparing Medistep Health with peers such as
Bajaj Consumer Care Ltd, assessing management quality becomes vital. Are Medistep Health's operational decisions and capital allocation strategies as effective as those observed in more established players?A significant highlight for Medistep Health is its ROCE of 37.83%. This strong return on capital employed indicates efficient utilization of capital in generating profits. A high ROCE can act as a moat, signaling a competitive advantage. It suggests that the company is potentially able to reinvest profits at a high rate of return, which can fuel future growth and further solidify its market position. This ability to generate such a strong return suggests pricing power and effective operational management. However, it's important to examine the sustainability of this ROCE. Can Medistep Health maintain this level of performance given the competitive landscape and potential for margin compression? Further investigation into the drivers of this high ROCE, such as unique product offerings or cost advantages, is warranted.
In conclusion, while the current Medistep Health share price and financial metrics present an interesting snapshot, a deeper dive into the company’s competitive positioning, management effectiveness, and sustainability of its high ROCE is crucial for a comprehensive understanding of its long-term financial stability. This analysis is purely observational and does not constitute investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Medistep Health Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDISTEP across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (29.02%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (37.83%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 6.54 vs Industry: 50.39)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (75.74%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (65.04%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.02)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (726.00x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (68.96%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Medistep Health Financial Statements
Comprehensive financial data for Medistep Health including income statement, balance sheet and cash flow
About MEDISTEP (Medistep Health)
Medistep Health (MEDISTEP) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Personal Care sector with a current market capitalisation of ₹35.52 (Cr). Medistep Health has delivered a Return on Equity (ROE) of 29.02% and a ROCE of 37.83%. The debt-to-equity ratio stands at 0.02, reflecting the company's capital structure. Investors tracking MEDISTEP share price can monitor key metrics including P/E ratio, promoter holding of 68.96%, and quarterly earnings growth.
Company Details
MEDISTEP Share Price: Frequently Asked Questions
What is the current share price of Medistep Health (MEDISTEP)?
As of 18 Mar 2026, 10:19 am IST, Medistep Health share price is ₹18.75. The MEDISTEP stock has a market capitalisation of ₹35.52 (Cr) on NSE/BSE.
Is MEDISTEP share price Overvalued or Undervalued?
MEDISTEP share price is currently trading at a P/E ratio of 6.54x, compared to the industry average of 50.39x. Based on this relative valuation, the Medistep Health stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of MEDISTEP share price?
The 52-week high of MEDISTEP share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Medistep Health share price?
Key factors influencing MEDISTEP share price include quarterly earnings growth (Sales Growth: 65.04%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Medistep Health a good stock for long-term investment?
Medistep Health shows a 5-year Profit Growth of N/A% and an ROE of 29.02%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.02 before investing in MEDISTEP shares.
How does Medistep Health compare with its industry peers?
Medistep Health competes with major peers in the Personal Care. Investors should compare MEDISTEP share price P/E of 6.54x and ROE of 29.02% against the industry averages to determine competitive standing.
What is the P/E ratio of MEDISTEP and what does it mean?
MEDISTEP share price has a P/E ratio of 6.54x compared to the industry average of 50.39x. Investors pay ₹7 for every ₹1 of annual earnings.
How is MEDISTEP performing according to Bull Run's analysis?
MEDISTEP has a Bull Run fundamental score of 56/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does MEDISTEP belong to?
MEDISTEP operates in the Personal Care industry. This classification helps understand the competitive landscape and sector-specific trends affecting Medistep Health share price.
What is Return on Equity (ROE) and why is it important for MEDISTEP?
MEDISTEP has an ROE of 29.02%, which indicates excellent management efficiency. ROE measures how efficiently Medistep Health generates profits from shareholders capital.
How is MEDISTEP debt-to-equity ratio and what does it indicate?
MEDISTEP has a debt-to-equity ratio of 0.02, which indicates conservative financing with low financial risk.
What is MEDISTEP dividend yield and is it a good dividend stock?
MEDISTEP offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Medistep Health shares.
How has MEDISTEP share price grown over the past 5 years?
MEDISTEP has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in MEDISTEP and why does it matter?
Promoters hold 68.96% of MEDISTEP shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Medistep Health.
What is MEDISTEP market capitalisation category?
MEDISTEP has a market capitalisation of ₹36 crores, placing it in the Small-cap category.
How volatile is MEDISTEP stock?
MEDISTEP has a beta of N/A. A beta > 1 suggests the Medistep Health stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is MEDISTEP operating profit margin trend?
MEDISTEP has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is MEDISTEP quarterly performance?
Recent quarterly performance shows Medistep Health YoY Sales Growth of 65.04% and YoY Profit Growth of 75.74%.
What is the institutional holding pattern in MEDISTEP?
MEDISTEP has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Medistep Health stock.